New drug combo tested for tough bile duct cancers

NCT ID NCT05712356

Terminated Disease control Sponsor: Lisata Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug called LSTA1 added to standard treatment for people with advanced bile duct or gallbladder cancer. The goal was to see if the combination is safe and works better than standard treatment alone. The trial was stopped early, and results are not yet available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bile duct cancer bile duct neoplasm cholangiocarcinoma Disease Progression extrahepatic bile duct carcinoma gallbladder cancer gallbladder carcinoma gallbladder neoplasm intrahepatic cholangiocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILE DUCT CANCER CHOLANGIOCARCINOMA EXTRAHEPATIC CHOLANGIOCARCINOMA GALL BLADDER CANCER GALL BLADDER CARCINOMA GALLBLADDER CANCER GALLBLADDER CARCINOMA INTRAHEPATIC CHOLANGIOCARCINOMA

Contacts and locations

Locations

Alliance for Multispecialty Research

Merriam, Kansas, 66204, United States
Banner MD Anderson Cancer Center

Gilbert, Arizona, 85234, United States
Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center

Cincinnati, Ohio, 45219, United States
FirstHealth of the Carolinas, Inc.

Pinehurst, North Carolina, 28374, United States
Inova Schar Cancer Institute

Fairfax, Virginia, 22031, United States
Mayo Clinic Arizona

Phoenix, Arizona, 85054, United States
Mayo Clinic Rochester

Rochester, Minnesota, 55905, United States
Moffitt Cancer Center

Tampa, Florida, 33612, United States
Northwell Health - Zuckerberg Cancer Center

Lake Success, New York, 11042, United States
Norton Cancer Institute, Audubon

Louisville, Kentucky, 40217, United States
Norton Cancer Institute, Downtown

Louisville, Kentucky, 40202, United States
Spartanburg Medical Center

Spartanburg, South Carolina, 29303, United States
Stony Brook Cancer Center

Stony Brook, New York, 11794, United States
The University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States
University of Arizona Cancer Center

Tucson, Arizona, 85719, United States
University of Kansas Cancer Center

Westwood, Kansas, 66205, United States
University of Kentucky Medical Center

Lexington, Kentucky, 40536, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States
Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.